Global β-Lactam Antibiotics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global β-Lactam Antibiotics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
β-lactam antibiotics refer to a large class of antibiotics with a β-lactam ring in their chemical structure. These antibiotics have the advantages of strong bactericidal activity, low toxicity, wide indications and good clinical efficacy.
β-Lactam Antibiotics report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global β-Lactam Antibiotics market is projected to reach US$ 37790 million in 2029, increasing from US$ 27220 million in 2022, with the CAGR of 4.8% during the period of 2024 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.
Antibiotics are a class of secondary metabolites produced by microorganisms (including bacteria, fungi, actinomycetes) or higher animals and plants in the course of life, which have anti-pathogen or other activities, and can interfere with the development and function of other living cells. . There are many kinds of antibiotics, which are mainly divided into two categoriesß-lactams and non-ß-lactams. Among them, ß-lactams have the most varieties and are the most widely used in clinical practice. From the perspective of medication structure, β-lactam antibiotics accounted for 55% of the anti-infective drugs in China. With the gradual recovery of the global economy, the continuous growth of the total population and the improvement of the aging society, the scale of the global pharmaceutical market has maintained a steady growth. From the perspective of the terminal market, the current global market size of antibiotic preparations is about 50 billion US dollars. Antibiotic products and markets are relatively mature, but due to the rigid demand for antibiotics in clinical treatment, the industry still shows a low growth trend.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global β-Lactam Antibiotics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
ACS Dobfar
CSPC
United Laboratories
Novartis
LKPC
Changsheng Pharma
North China Pharmaceuticals
Centrient Pharmaceutical
Aurobindo Pharma
Yili Chuanning Biotechnology
Jiangxi Fushine Pharmaceutical
QILU Pharmaceutical
Jiangxi Huabang Pharmaceutical
Segment by Type
Penicillin
Oxycephems
Carbapenems
Cephalosporins
Others
Hospital
Clinic
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the β-Lactam Antibiotics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of β-Lactam Antibiotics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the β-Lactam Antibiotics industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of β-Lactam Antibiotics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, β-Lactam Antibiotics introduction, etc. β-Lactam Antibiotics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of β-Lactam Antibiotics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
β-Lactam Antibiotics report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global β-Lactam Antibiotics market is projected to reach US$ 37790 million in 2029, increasing from US$ 27220 million in 2022, with the CAGR of 4.8% during the period of 2024 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.
Antibiotics are a class of secondary metabolites produced by microorganisms (including bacteria, fungi, actinomycetes) or higher animals and plants in the course of life, which have anti-pathogen or other activities, and can interfere with the development and function of other living cells. . There are many kinds of antibiotics, which are mainly divided into two categoriesß-lactams and non-ß-lactams. Among them, ß-lactams have the most varieties and are the most widely used in clinical practice. From the perspective of medication structure, β-lactam antibiotics accounted for 55% of the anti-infective drugs in China. With the gradual recovery of the global economy, the continuous growth of the total population and the improvement of the aging society, the scale of the global pharmaceutical market has maintained a steady growth. From the perspective of the terminal market, the current global market size of antibiotic preparations is about 50 billion US dollars. Antibiotic products and markets are relatively mature, but due to the rigid demand for antibiotics in clinical treatment, the industry still shows a low growth trend.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global β-Lactam Antibiotics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
ACS Dobfar
CSPC
United Laboratories
Novartis
LKPC
Changsheng Pharma
North China Pharmaceuticals
Centrient Pharmaceutical
Aurobindo Pharma
Yili Chuanning Biotechnology
Jiangxi Fushine Pharmaceutical
QILU Pharmaceutical
Jiangxi Huabang Pharmaceutical
Segment by Type
Penicillin
Oxycephems
Carbapenems
Cephalosporins
Others
Segment by Application
Hospital
Clinic
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the β-Lactam Antibiotics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of β-Lactam Antibiotics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the β-Lactam Antibiotics industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of β-Lactam Antibiotics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, β-Lactam Antibiotics introduction, etc. β-Lactam Antibiotics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of β-Lactam Antibiotics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices